Sinead A. O'ROurke

Sinead A. O'ROurke

Auto-generated profile, based on publicly available information

Sinead A. O'ROurke

School of Biochemistry and Immunology Trinity College Dublin Dublin Ireland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2019 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
SOSinead A. O'ROurke
Sinead A. O'ROurke
ADAisling Dunne
Aisling Dunne
MMMichael Monaghan
Michael Monaghan
Myocardial infarction is the most common form of acute cardiac injury attributing to heart failure. While there have been significant advances in current therapies, mortality and morbidity remain high. Emphasis on inflammation and extracellular matrix remodeling as key pathological factors has brought to light new potential therapeutic targets including macrophages which are central players in the inflammatory response following myocardial infarction. Blood derived and tissue resident macrophages exhibit both a pro- and anti-inflammatory phenotype, essential for removing injured tissue and facilitating repair, respectively. Sustained activation of pro-inflammatory macrophages evokes extensive remodeling of cardiac tissue through secretion of matrix proteases and activation of myofibroblasts. As the heart continues to employ methods of remodeling and repair, a destructive cycle prevails ultimately leading to deterioration of cardiac function and heart failure. This review summarizes not only the traditionally accepted role of macrophages in the heart but also recent advances that have deepened our understanding and appreciation of this dynamic cell. We discuss the role of macrophages in normal and maladaptive matrix remodeling, as well as studies to date which have aimed to target the inflammatory response in combatting excessive matrix deposition and subsequent heart failure.

25 May 2022 in Atherosclerosis
Verified
Journal Article
Open access
SOSinead A. O'ROurke
Sinead A. O'ROurke
NNNuno G.B. Neto
Nuno G.B. Neto
EDEimear Devilly
Eimear Devilly
LSLianne C. Shanley
Lianne C. Shanley
HFHannah K. Fitzgerald
Hannah K. Fitzgerald
ADAisling Dunne
Aisling Dunne
Metabolic reprogramming of innate immune cells is emerging as a key player in the progression of a number of chronic diseases, including atherosclerosis, where high rates of glycolysis correlate with plaque instability. This study aimed to investigate if cholesterol crystals, which are key atherosclerosis-associated DAMPs (damage/danger-associated molecular patterns), alter immune cell metabolism and whether this, in turn, impacts on macrophage phenotype and function. Primary human macrophages were treated with cholesterol crystals and expression of M1 (CXCL9, CXCL10) and M2-associated (MRC1, CCL13) macrophage markers, alarmins, and inflammatory cytokines were assessed either by real-time PCR or ELISA. Cholesterol crystal-induced changes in glycolytic markers were determined using real-time PCR and western blotting, while changes in cellular respiration and mitochondrial dynamics were examined via Seahorse analysis, Fluorescence Lifetime Imaging Microscopy (FLIM) and confocal microscopy. Treatment of macrophages with cholesterol crystals upregulated mRNA levels of CXCL9 and CXCL10, while concomitantly downregulating expression of MRC1 and CCL13. Cholesterol crystal--treated macrophages also exhibited a significant shift in metabolism to favour glycolysis, accompanied by the expression of key glycolytic markers GLUT1, Hexokinase 2, HIF1α, GAPDH and PFKFB3. Furthermore, we show that these effects are mediated upstream by the glycolytic enzyme, PKM2, and that direct inhibition of glycolysis or PKM2 nuclear localisation leads to a significant reduction in cholesterol crystal-induced inflammatory readouts. This study not only provides further insight into how atherosclerosis-associated DAMPs impact on immune cell function, but also highlights metabolic reprogramming as a potential therapeutic target for cholesterol crystal-related inflammation.

1 September 2017 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
PDF file
SIShakeel Inder
Shakeel Inder
SOSinead O'Rourke
Sinead O'Rourke
NMNiamh McDermott
Niamh McDermott
RMRustom Manecksha
Rustom Manecksha
SFStephen Finn
Stephen Finn
LMLaure Marignol
Laure Marignol

2 September 2025 in Cell Reports Physical Science
Verified
Journal Article
Open access
SOSinead A. O’ROurke
Sinead A. O’ROurke
MSMeenakshi Suku
Meenakshi Suku
SPStéphane Petrousek
Stéphane Petrousek
DHDavid A. Hoey
David A. Hoey
ADAisling Dunne
Aisling Dunne
MMMichael G. Monaghan
Michael G. Monaghan

22 October 2026 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Open access
PDF file
SOSinead A. O'ROurke
Sinead A. O'ROurke
GGGiovanni Gonnella
Giovanni Gonnella
GKGabriela S. Kronemberger
Gabriela S. Kronemberger
SPStéphane Petrousek
Stéphane Petrousek
DHDavid A. Hoey
David A. Hoey
DKDaniel J. Kelly
Daniel J. Kelly
Articular cartilage (AC) repair remains a major clinical challenge due to its limited healing capacity and the inability of current treatment strategies to restore long‐term function. Biomaterial‐based strategies which support favorable immune responses and appropriate progenitor cell function have shown promise in enhancing cartilage regeneration. We and others have previously demonstrated the capacity of extracellular matrix (ECM)‐based materials to direct both innate immune cell behavior and progenitor cell differentiation, with these effects highly dependent on the ECM tissue of origin. Building on these observations, we now aim to further investigate the immunomodulatory properties of AC‐derived ECM (AC‐ECM) materials. Using primary human macrophages, we demonstrate that AC‐ECM material promotes a metabolically active mixed response in macrophages, with elevated expression of reparative growth factors conducive to chondrogenesis. Furthermore, AC‐ECM limits inflammatory activation of primary human macrophages, as demonstrated by reduced metabolic reprogramming and inflammatory cytokine production. Functionally, macrophages treated with AC‐ECM enhance cartilage regeneration by increasing chondrogenic marker expression in mesenchymal stem cells, while also suppressing angiogenic tube formation in endothelial cells. Overall, this work demonstrates that AC‐ECM biomaterials can direct macrophage phenotype toward a pro‐chondrogenic state, offering a promising strategy for the development of more effective and durable cartilage repair therapies.